AIM IMMUNOTECH INC. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
AIM IMMUNOTECH INC. (AIM) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $52.00 thousand as of 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2022-03-31
- 2020-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $52.00K.
- 2015-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2015-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2015-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $5.00K.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2020-12-31 | $52.00K 10-K · filed 2022-03-31 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 |
| 2015-03-31 | $5.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |